CLINICAL_TRIALS trial_result · 2024-04-17

Clinical Trial Update: ART First-line Treatment Durability in Russia

A completed clinical trial update reports on first-line ART durability in people with HIV-1 infection in Russia, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: MSD Pharmaceuticals LLC | Conditions: HIV-1-infection | Status: COMPLETED | Results posted: 2024-04-17